title: [Recombinant human growth hormone (rhGH) administration in a patient with chronic renal insufficiency: renal and metabolic effects].
abstract: We report the renal and metabolic effects of a 40 day administration of recombinant human growth hormone in a 31 years old diabetic and GH-deficient patient who underwent a kidney and pancreas transplantation. The data show an increase in glomerular filtration rate, tubular reabsorption of phosphate, and plasma hemoglobin level. Anabolism is suggested from a decrease in serum urea nitrogen and an increase in muscle mass (increase in plasma creatinine). These positive effects might be partly explained by an overcome of endogenous growth hormone resistance when administering pharmacological doses of recombinant growth hormone.
authors.affiliation: Départment de néphrologie, Hôpital E. Herriot, Lyon.
authors.forename: D
authors.initials: D
authors.lastname: Fouque
authors.forename: S
authors.initials: S
authors.lastname: Bernard
authors.forename: A
authors.initials: A
authors.lastname: Hadj-Aïssa
authors.forename: M
authors.initials: M
authors.lastname: Laville
authors.forename: P
authors.initials: P
authors.lastname: Zech
authors.forename: J P
authors.initials: JP
authors.lastname: Riou
mesh_terms: D000328:Adult; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000628:therapy; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage / Q000172:deficiency* / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D016030:Kidney Transplantation; D016035:Pancreas Transplantation; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D006454:Hemoglobins; D011994:Recombinant Proteins; D013006:Growth Hormone; D003404:Creatinine
vernacular_title: Administration d'hormone de croissance recombinante humaine (rhGH) chez une patiente insuffisante rénale chronique: effets rénaux et métaboliques.